Старение. Профессиональный врачебный подход

   131. Martínez Velilla N.I., Gaminde Inda I. Comorbidity and multi morbidity indexes in the elderly patients. Med Clin (Barc). 2011 Apr 16; 136(10):441–6

   132. Mathur R., Hull S. A., Badrick E., Robson J. Cardiovascular multimorbidity: the effect of ethnicity on prevalence and risk factor management.Br J Gen Pract. 2011 May; 61(586): P. 262–70.

   133. Matsumoto A. M., Marck В.Т., Gruenewald D.A. Aging and the neuroen-docrine regulation and body weight//Exp. Gerontol. 2000. Vol.35. P. 1251–1265.

   134. Mattison J. Ames dwarf mice: a model for delayed aging // Успехи геронтологии 2000. Т. 4. С. 141–146.

   135. Mayersofat M. Pharmacokinetics in the elderly if Environ Health Perspectives Suppl 11. 1994. Vol. 102. P. 119–124.

   136. McCleam G.E. Biomarkers of age and aging. Exp. Gerontol. 1997. Vol. 32. P. 87–94.

   137. Medvedev Z. A. Possible role of repeated nucleotide sequences in DNA in the evolution of life spans of different cells. Nature. 1972. Vol. 237. P. 453–454.

   138. Meichnikoff E. Etudes sur la nature humaine: Essai de philosophie optimiste // Paris: Masson & C-ie, 1903. 399 p.

   139. Men T. Russian mortality trends for 1991–2001: analysis by cause and region // BMJ 2003; 327: 964.

   140. Michelson H., Bolund C., Brandberg Y. Multiple chronic health problems are negatively associated with health related quality of life (HRQOL) irrespective of age // Qual Life Res, 2000; 9: 1093–1104.

   141. Miller M.D., Paradis C.F., Houck P.R., Mazumdar S., Stack J.A., Rifai A.H. Rating chronic medical illness burden in geropsychiatric practice and research: application of the Cumulative Illness Rating Scale // Psychiatry Res, 1992; 41:237e48.

   142. Miller M.D., Towers A. Manual of Guidelines for Scoring the Cumulative Illness Rating Scale for Geriatrics (CIRS-G) // Pittsburg, Pa: University of Pittsburgh; 1991.

  143. Miyaishi O., Ando F., Matsuzawa K, et al. Cancer incidence in old age. Mech. Ageing Dev. 2000. Vol. 117. P. 47–55.

   144. Morley A.A. The somatic mutation theory of ageing Mutat. Res. 1995. Vol. 338. P. 19–23.

   145. Munoz E., Rosner F., Friedman R., Sterman H., Goldstein J., Wise L. Financial risk, hospital cost, complications and comorbidities in medical non-complications and comorbidity-stratified diagnosis-related groups // Am J Med, 1988; 84(5):933-9

   146. Nabeshima Y. Klotho: a fundamental regulator of aging. Ageing Res. Rev. 2002. Vol. 1. P. 627–638.

   147. Nickenig G., Harrison, D.G. The AT(1)-type angiotensin receptor in oxidative stress and atherogenesis: part I: oxidative stress and atherogenesis // Circulation 2002; 105: 393–396.

   148. Nordam A., Sorlie V., Forde R. Integrity in the care of elderly people, as narrated by female physicians. Nurs. Ethics. 2 003. Vol. 10(4). Р. 388–403.

   149. Oilman V. M. Development, Aging and Disease. A New Rationale for an Intervention Strategy. Chun Harwood Academic Publ., 1994, 387 p.

   150. Ono Т., Uehara K, KurishitaA. et al. Biological significance of DNA methyla-tion in the aging process. Age & Aging. 1993. Vol. 22. P. 534–543.

   151. Opie L.H. Mechanisms of cardiac contraction and relaxation // Braunwald’s heart disease: a textbook of cardiovascular medicine. Ed. D. Zipes, P. Libby, R.O. Bonow, Braunwald E. 7ed. Pensylvania: Elsevier Saunders, 2005: 457–490.

   152. Papa S., Skuktchev V.P. Reactive oxygen species, mitochondria, apoptosis and aging. Molec. Cell. Biochem. 1997. Vol. 174. P. 305–319.

   153. Perruccio A.V., Katz J.N., Losina E. Health burden in chronic disease: multimorbidity is associ ated with self-rated health more than medical comorbidity alone. J Clin Epidemiol. 2011 Aug 9.

   154. Peto R., Doll R. There is no such thing as aging. Br. J. Med. 1997. Vol. 315. P. 1030–1032.

   155. Pilz S. Elevated plasma free fatty acids predict sudden cardiac death: a 6.85-year follow-up of 3315 patients after coronary angiography // Eur Heart J. 2007; 28(22):2763–2769.

   156. Pincus T., Kallahan L.F. Taking mortality in rheumatoid arthritis seriously: Predictive markers, socioeconomic status and comorbidity // J. Rheumatol, 1996. Vol.13. P. 841–845.

   157. Pletcher S.D., Neuhauser C. Biological aging – Criteria for modelling and a new mechanistic model. Int. J. Modem Physcis. 2000. Vol. 11. P. 525–546.

   158. Qungquht В., Berg S., Lanke J. et al. The effect of genetic factors for longevity: a comparison of identical and fraternal twins in the Swedish Twin Registry. J. Gerontol. A B iol. Sci. Med. Sci. 1998. Vol. 53. P. M441–M446.

   159. Rahman K. Garlic and aging: new isights into an old remedy. Ageing Res. Rev. 2003. Vol. 2. P. 39–56.

   160. Richardson K., Ananou A., Lafortune L., Brayne C., Matthews F.E. Variation over time in the association between polypharmacy and mortality in the older population.Drugs Aging. 2011 Jul 1;28(7):547-60.

   161. Robine J.M., Saito Y., Jagger С. The emergence of exltemely old people: the case of Japan // Exp. Gerontol. 2003. Vol. 38. P. 735–739.